Deoxyuridine triphosphatase (dUTPase) expression and sensitivity to the thymidylate synthase (TS) inhibitor ZD9331

British Journal of Cancer

Volumn 83, Issue 6, 2000, Pages 792-799

  Webley, S D ^a   Hardcastle, A ^a   Ladner, R D ^b   Jackman, A L ^a   Aherne, G W ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

DUTP; DUTPase; In vitro sensitivity; Thymidylate synthase; ZD9331

Indexed keywords

CELL ENZYME; DEOXYURIDINE TRIPHOSPHATE PYROPHOSPHATASE; PLEVITREXED; QUINAZOLINE DERIVATIVE; THYMIDYLATE SYNTHASE; THYMIDYLATE SYNTHASE INHIBITOR;

ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; ENZYME ACTIVITY; ENZYME INHIBITION; EXCISION REPAIR; HUMAN; HUMAN CELL; HYDROLYSIS; LUNG TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0033811850     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1358     Document Type: Article

References (43)

1. The role of uracil misincorporation in thymineless death
2. Immunoreactive dUMP and TTP pools as an index of thymidylate synthase inhibition; effect of Tomudex (ZD1694) and a nonpolyglutamated quinazoline antifolate (CB30900) in L1210 mouse lenkaemia cells
3. In vitro and in vivo pharmacology of the non-polyglutamated quinazoline antifolate thymidylate synthase (TS) inhibitor, ZD9331
4. Enhancement of methotrexate cytotoxicity by uracil analogues that inhibit deoxyuridine triphosphate nucleotidohydrolase (dUTPase) activity
5. Quinazotine antifolates with dual biochemical loci of action. Biochemical and biological studies directed towards overcoming methotrexate resistance
6. Resistance to fluorodeoxyuridine induced DNA damage and cytotoxicity correlates with an elevation of deoxyuridine triphosphatase activity and failure to accumulate deoxyuridine triphosphate
7. Induction of resistance to fluorodeoxyuridine cytotoxicity and DNA damage in human tumour cells by expression of Escherichia coli deoxyuridine triphosphatase
8. Purification and properties of the deoxyuridine triphosphate nucleotidohydrolase enzyme derived from HeLa S3 cells: Comparison to a distinct dUTP nucleotidohydrolase induced in herpes simplex virus-infected Hela S3 cells
9. On the nature of thymineless death
10. Thymidylate synthase gene amplification in human colon cancer Cell lines resistant to 5-fluorouracil
11. Mechanisms of cell death following thymidylate synthase inhibition: 2 Deoxyuridine 5 triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole
12. The relationship between intrinsic thymidylate synthase expression and sensitivity to thymilaq in human leukaemia and colorectal carcinoma Cell lines
13. Lack of correlation between thymidylate synthase levels in primary colorectal tumours and subsequent response to therapy
14. Bcl-2 modulation apoptosis induced by anticancer drugs-resistance to thymidylate stress is independent of classical resistance pathways
15. Molecular characterization of two cell lines selected for resistance to the folate-based thymidylate synthase inhibition, ZD 1694
16. Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells
17. Thymineless death in colon carcinoma cells is mediated via Fas signaling
18. Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells
19. The new generation of thymidylate synthase inhibitors in clinical study
20. 10-propargyl-5-8-dideazafolic acid (CB3717): Development, characterization, and cross resistance studies
21. Mechanisms of acquired resistance to the quinazoline thymidylate synthase inhibitor ZD1694 (Tomudex) in one mouse and three human cell lines
22. Cellular pharmacology and in vivo activity of a new anticancer agent ZD9331: A water-soluble, nonpolyglutamatable, quinazoline inhibitor of thymidylate synthase
23. Biochemical effects of a quinazoline inhibitor of thymidylate synthetase, N-(4-(N-((2-amino-4-hydroxy-6-quinazolinyl)-methyl)prop-2-ynylamino)benzoy)-L -glutamic acid (CB3717), on human lymphoblastoid cells
24. The rule of thymidylate synthase expression in prognosis and outcome or adjuvant chemotherapy in patients with rectal cancer
25. Thymidylate synthase gent and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumours
26. Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer
27. Desensitization and sensitization of cells to fluoropyrimidines with different antisense directed against thymidylate synthase messenger RNA
28. Effect of hammerhead ribozyme against human thymidylate synthase on the cytotoxicity of thymidylate inhibitors
29. Lowering dUTPase levels through antisense induces sensitivity to fluorodeoxyuridine in HT29 cells
30. Characterization of distinct nuclear and mitochondrial forms of human deoxyuridine triphosphate nucleotidohydrolase
31. Thymidylate synthase mRNA level in adenocarcinoma of the stomach: A predictor for primary turnout response and overall survival
32. DNA glycosylases, endonucleases for apurinic/apyrimidinic sites, and base excision repair
33. Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl N10 propargyl-5, 8-dideazafolic acid: A novel folate based TS inhibitor
34. Mechanism and pharmacological specificity of dUTPase-mediated protection from DNA damage and cytotoxicity in human tumor cells
35. Prognostic importance of thymidylate synthase expression in early breast cancer
36. Acquisition of resistance to antifolates caused by enhanced (-glutamyl hydrolase activity
37. Cell cycle effects of CB30865, a lipophilic quinazoline-based analogue of the antifolate thymidylate synthase inhibitor ICI 198583 with an undefined mechanism of action
38. Thymidylate synthase inhibition in malignant tumours and normal liver of patients given intraveneous 5-fluorouracil
39. Maturation stage and proliferatopm-dependent expression of dUTP Pase in human T-cells
40. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines
41. AG337 is a novel lipophilic thymidylate synthase inhibitor: In vitro and in vivo preclinical studies